Live feed
Filing
SC 13G
SC 13G0001683168-20-001922·BRISTOL INVESTMENT FUND LTD
Schedule 13G ownership disclosure
GT Biopharma, Inc.
Security class unavailable · CUSIP: 36254L100
Event date: 2020-06-08
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.3600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001683168-20-001922
- Form type
- SC 13G
- Filer
- BRISTOL INVESTMENT FUND LTD
- CIK
- CIK 1174866
- Filed
- Jun 10, 2020
- Reporting period
- Jun 08, 2020
- Description
- Schedule 13G beneficial ownership